These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7511033)
1. Effects of intrahippocampal colchicine administration on the levels and localization of microtubule-associated proteins, tau and MAP2. Geddes JW; Bondada V; Keller JN Brain Res; 1994 Jan; 633(1-2):1-8. PubMed ID: 7511033 [TBL] [Abstract][Full Text] [Related]
2. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. Geddes JW; Schwab C; Craddock S; Wilson JL; Pettigrew LC J Cereb Blood Flow Metab; 1994 Jul; 14(4):554-64. PubMed ID: 7516935 [TBL] [Abstract][Full Text] [Related]
3. Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Schwab C; Bondada V; Sparks DL; Cahan LD; Geddes JW Hippocampus; 1994 Apr; 4(2):210-25. PubMed ID: 7951696 [TBL] [Abstract][Full Text] [Related]
4. Chronic restraint stress alters the expression and distribution of phosphorylated tau and MAP2 in cortex and hippocampus of rat brain. Yan J; Sun XB; Wang HQ; Zhao H; Zhao XY; Xu YX; Guo JC; Zhu CQ Brain Res; 2010 Aug; 1347():132-41. PubMed ID: 20513368 [TBL] [Abstract][Full Text] [Related]
5. Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons. Mattson MP Brain Res; 1992 Jun; 582(1):107-18. PubMed ID: 1354011 [TBL] [Abstract][Full Text] [Related]
6. Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism. Implications for Alzheimer disease. Geddes JW; Pang Z; Wiley DH Mol Chem Neuropathol; 1996; 28(1-3):65-74. PubMed ID: 8871943 [TBL] [Abstract][Full Text] [Related]
7. The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles. Xie C; Miyasaka T; Yoshimura S; Hatsuta H; Yoshina S; Kage-Nakadai E; Mitani S; Murayama S; Ihara Y PLoS One; 2014; 9(2):e89796. PubMed ID: 24587039 [TBL] [Abstract][Full Text] [Related]
8. Developmental changes of MAP2 immunoreactivity in the hippocampus proper and dentate gyrus of the rat. Biranowska J; Berdel B; Ludkiewicz B; Dziewiatkowski J; Jagalska-Majewska H; Moryś J Folia Neuropathol; 2000; 38(1):1-6. PubMed ID: 11057027 [TBL] [Abstract][Full Text] [Related]
9. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Davis DR; Brion JP; Couck AM; Gallo JM; Hanger DP; Ladhani K; Lewis C; Miller CC; Rupniak T; Smith C Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):941-9. PubMed ID: 7639714 [TBL] [Abstract][Full Text] [Related]
10. Neuronal loss and cytoskeletal disruption following intrahippocampal administration of the metabolic inhibitor malonate: lack of protection by MK-801. Pang Z; Umberger GH; Geddes JW J Neurochem; 1996 Feb; 66(2):474-84. PubMed ID: 8592116 [TBL] [Abstract][Full Text] [Related]
11. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Brion JP; Octave JN; Couck AM Neuroscience; 1994 Dec; 63(3):895-909. PubMed ID: 7898684 [TBL] [Abstract][Full Text] [Related]
12. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau. Xie C; Soeda Y; Shinzaki Y; In Y; Tomoo K; Ihara Y; Miyasaka T J Neurochem; 2015 Oct; 135(1):19-26. PubMed ID: 26134402 [TBL] [Abstract][Full Text] [Related]
13. Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Irving EA; McCulloch J; Dewar D Acta Neuropathol; 1996 Aug; 92(2):186-96. PubMed ID: 8841665 [TBL] [Abstract][Full Text] [Related]
14. Changes in microtubule-associated protein-2 (MAP2) expression during development and after status epilepticus in the immature rat hippocampus. Jalava NS; Lopez-Picon FR; Kukko-Lukjanov TK; Holopainen IE Int J Dev Neurosci; 2007 Apr; 25(2):121-31. PubMed ID: 17229541 [TBL] [Abstract][Full Text] [Related]
15. Short- and long-term treatment with estradiol or progesterone modifies the expression of GFAP, MAP2 and Tau in prefrontal cortex and hippocampus. Camacho-Arroyo I; González-Arenas A; Espinosa-Raya J; Piña-Medina AG; Picazo O Life Sci; 2011 Jul; 89(3-4):123-8. PubMed ID: 21683086 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448 [TBL] [Abstract][Full Text] [Related]
17. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. Yen SH; Dickson DW; Crowe A; Butler M; Shelanski ML Am J Pathol; 1987 Jan; 126(1):81-91. PubMed ID: 2433949 [TBL] [Abstract][Full Text] [Related]
19. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Holzer M; Gärtner U; Stöbe A; Härtig W; Gruschka H; Brückner MK; Arendt T Acta Neuropathol; 2002 Nov; 104(5):471-81. PubMed ID: 12410395 [TBL] [Abstract][Full Text] [Related]